Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 47.19 K87.17 K152.96 K178.74 K185.84 K 604.71 K Research & development ————— — Operating income -47.19 K-87.17 K-152.96 K-178.74 K-185.84 K -604.71 K Non-Operating Income, Total 0-273.52 K2.26 M2.11 M1.94 M 6.04 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 0-273.52 K2.26 M2.11 M1.94 M 6.04 M Unusual income/expense ————— — Pretax income -47.19 K-360.69 K2.11 M1.93 M1.76 M 5.44 M Equity in earnings ————— — Taxes ————— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -47.19 K-360.69 K2.11 M1.93 M1.76 M 5.44 M Discontinued operations ————— — Net income -47.19 K-360.69 K2.11 M1.93 M1.76 M 5.44 M Dilution adjustment ——217.98 M—222.01 M — Preferred dividends ——217.98 M—222.01 M — Diluted net income available to common stockholders 47.19 K360.69 K2.11 M1.12 M1.76 M 5.34 M Basic earnings per share (Basic EPS) -0.01-0.040.070.170.06 0.26 Diluted earnings per share (Diluted EPS) -0.01-0.040.070.160.06 0.25 Average basic shares outstanding 6.88 M6.93 M7.51 M7.77 M8.51 M — Diluted shares outstanding 6.88 M7.93 M8.14 M8.03 M8.51 M — EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) ————— —